Jackson Square Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21M Buy
34,967
+25,266
+260% +$2.92M 0.88% 29
2025
Q4
$1.02M Buy
+9,701
New +$911K 0.2% 71
2025
Q1
Sell
-6,164
Closed -$613K 157
2024
Q4
$613K Sell
6,164
-15,684
-72% -$1.62M 0.15% 104
2024
Q3
$2.48M Sell
21,848
-31,156
-59% -$3.7M 0.62% 42
2024
Q2
$6.56M Buy
53,004
+760
+1% +$97.9K 1.61% 15
2024
Q1
$6.89M Buy
52,244
+15,615
+43% +$1.92M 1.77% 15
2023
Q4
$3.99M Buy
36,629
+79
+0.2% +$8.2K 1.28% 22
2023
Q3
$3.76M Sell
36,550
-8,976
-20% -$967K 1.51% 22
2023
Q2
$5.25M Sell
45,526
-450
-1% -$51.1K 2.11% 15
2023
Q1
$4.89M Buy
45,976
+39,119
+570% +$4.22M 2.19% 13
2022
Q4
$761K Sell
6,857
-13
-0.2% -$1.33K 0.36% 66
2022
Q3
$592K Buy
6,870
+76
+1% +$6.79K 0.29% 70
2022
Q2
$619K Sell
6,794
-31
-0.5% -$2.75K 0.26% 73
2022
Q1
$560K Sell
6,825
-860
-11% -$67.8K 0.17% 105
2021
Q4
$589K Buy
7,685
+3,875
+102% +$309K 0.17% 112
2021
Q3
$286K Buy
3,810
+946
+33% +$71.9K 0.09% 153
2021
Q2
$223K Sell
2,864
-5,431
-65% -$404K 0.07% 171
2021
Q1
$610K Sell
8,295
-22,883
-73% -$1.69M 0.23% 82
2020
Q4
$2.43M Sell
31,178
-3,714
-11% -$284K 0.94% 38
2020
Q3
$2.76M Sell
34,892
-3,057
-8% -$239K 1.22% 35
2020
Q2
$2.8M Buy
37,949
+25,114
+196% +$1.89M 1.41% 28
2020
Q1
$942K Buy
12,835
+1,918
+18% +$151K 0.73% 45
2019
Q4
$947K Buy
+10,917
New +$897K 0.55% 57

Other funds holding MRK

Jackson Square Capital's MRK Position: Q1 2026 in Review

Jackson Square Capital increased its Merck (MRK) stake by 260% in Q1 2026, buying an estimated $2.92M and bringing the position to 34,967 shares worth $4.21M. The position accounts for 0.88% of the portfolio, ranked #29.

Jackson Square Capital first reported a position in MRK in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.89M in Q1 2024. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jackson Square Capital held 34,967 shares of Merck worth $4.21M as of Q1 2026.
  • Jackson Square Capital bought 25,266 Merck shares in Q1 2026, an estimated $2.92M.
  • Merck made up 0.88% of Jackson Square Capital's portfolio in Q1 2026, its #29 holding.
  • Jackson Square Capital first reported a position in Merck in Q4 2019 and has held it in 23 quarters since.
  • Jackson Square Capital's Merck position peaked at $6.89M in Q1 2024.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jackson Square Capital's 13F filing for Q1 2026, filed 13 Apr 2026.